McKechnie Duncan

McKechnie Duncan is listed in filings as EVP at Vertex Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Mar 13, 2026, including sale activity. Recent filings connect the profile to Vertex Pharmaceuticals Inc (VRTX). The current snapshot covers public activity from Jan 26, 2026 to Mar 13, 2026. Reported amounts are shown as $527.9K to $555.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.